Questions: Protein Aggregation and Neurodegeneration

Question 1

Researchers studying Alzheimer's disease find that reducing amyloid-β plaques in mouse models does not always improve cognitive outcomes as much as expected. Which finding about protein toxicity best explains this?

• A. Large, mature amyloid fibrils are the most toxic species and must be completely eliminated to see improvement
• B. Small oligomeric intermediates — not large plaques — appear to be the most acutely neurotoxic species, so reducing plaques may not address the most damaging form
• C. Amyloid-β plaques are extracellular and therefore cannot directly damage neurons, making plaque reduction irrelevant
• D. Alzheimer's disease is caused by tau alone, so targeting amyloid-β misses the culprit

Answer: (B)

Current evidence suggests that small amyloid-β oligomers — the intermediate assemblies between soluble monomers and large insoluble fibrils/plaques — are the most acutely toxic species. Oligomers insert into membranes, disrupt ion gradients, and form pores. Large, mature plaques may represent a relatively inert endpoint. If therapies target established plaques but not oligomers, they may reduce aggregate burden while leaving the most toxic species intact — which helps explain why plaque reduction alone has had modest clinical benefit.

Question 2

The stereotyped spread of α-synuclein pathology in Parkinson's disease — following the Braak staging pattern from brainstem toward cortex — is best explained by which mechanism?

• A. α-synuclein is synthesized primarily in brainstem neurons, which are first affected by mitochondrial dysfunction
• B. Prion-like propagation: misfolded α-synuclein released from one neuron seeds misfolding of normally folded α-synuclein in anatomically connected recipient neurons
• C. The brainstem is exposed to environmental toxins first, and damage diffuses upward through cerebrospinal fluid
• D. Dopaminergic neurons are uniquely vulnerable to oxidative stress, and this vulnerability increases from brainstem to cortex

Answer: (B)

The prion-like propagation model explains Braak staging: misfolded α-synuclein released from a neuron (or transmitted via exosomes) is taken up by connected neurons and seeds local misfolding there, propagating pathology in an anatomically patterned way following neural connectivity. 'Prion-like' is a mechanistic label — Parkinson's is not infectious — it captures the templated, self-propagating nature of the conformation change that drives the predictable anatomical progression.

Question 3

In Alzheimer's disease, amyloid-β accumulates inside neurons as intracellular inclusions, while tau forms extracellular tangles in the surrounding brain tissue.

• T. True
• F. False

Answer: False

The locations are reversed. Amyloid-β (Aβ) is a peptide cleaved from APP that accumulates outside neurons as extracellular plaques. Tau is a microtubule-stabilizing protein that, when hyperphosphorylated in disease, detaches from microtubules and forms intracellular neurofibrillary tangles inside neurons. This distinction matters clinically: therapeutic strategies differ depending on whether you are targeting extracellular plaques (amenable to antibody clearance) or intracellular tangles (harder to access).

Question 4

Protein aggregates in neurodegenerative diseases can impair the ubiquitin-proteasome system and autophagy, creating a positive feedback loop where aggregation begets further aggregation.

• T. True
• F. False

Answer: True

Normally, the ubiquitin-proteasome system and autophagy clear misfolded proteins before they aggregate. But amyloid aggregates are structurally resistant to these pathways, and their accumulation can physically clog and functionally impair these clearance systems. With clearance machinery compromised, newly misfolded proteins are not removed, leading to further aggregation. This positive feedback loop explains why neurodegeneration can accelerate over time even from a small initial nucleation event.

Question 5

Explain what 'prion-like propagation' means in the context of neurodegenerative disease, and why the discovery of this mechanism matters for understanding disease progression even though these diseases are not infectious.

Model answer: Prion-like propagation means a misfolded protein conformation acts as a template, inducing correctly folded copies of the same protein to adopt the pathogenic conformation. In neurodegenerative disease, misfolded proteins (α-synuclein, tau, Aβ) released from one neuron can be taken up by connected neurons and seed local misfolding there, propagating pathology in an anatomically patterned way. 'Prion-like' refers to the mechanism (templated self-propagation), not infectivity — these diseases are not transmitted between people.

The clinical importance is substantial: if spread follows neural connectivity in a templated manner, early intervention before propagation — or blocking the spread mechanism — might contain disease to its origin rather than letting it propagate through the brain. This reframes neurodegeneration from an inevitable diffuse process to a potentially containable one, and explains why disease progression follows predictable anatomical patterns (like Braak staging) that can be used to assess disease phase.